Sanofi Aktie

45,80 EUR +0,80 EUR +1,78 %

12:59:17

STU

50,12 USD -1,87 USD -3,60 %

vorbörslich13:06:52

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

KGV20,07

WKN662283

ISINUS80105N1054

SymbolSNY

Sanofi Aktien News

Sortieren:Datum Meistgelesen

03.04.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - February 2025

03.04.25BenzingaWhy Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?

03.04.25BenzingaLamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday

WerbungSanofi-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

03.04.25GlobeNewswirePress Release: Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

28.03.25GlobeNewswirePress Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

28.03.25GlobeNewswirePress Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD

26.03.25GlobeNewswirePress Release: Chlamydia vaccine candidate granted fast track designation by the US FDA

25.03.25GlobeNewswirePress Release: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

24.03.25GlobeNewswirePress Release: Availability of the Q1 2025 Aide mémoire

20.03.25ZacksSanofi Inks $1.9B Deal With Dren Bio to Buy Autoimmune Disease Drug

20.03.25BenzingaSanofi Strengthens Its Immune System-Focused Pipeline With Around $2 Billion Dren Bio Deal

20.03.25GlobeNewswirePress Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline

14.03.25PR NewswireSanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season

12.03.25BenzingaSanofi Stock Forms Golden Cross As Dupixent Eyes FDA Green Light: Can The Bullish Run Continue?

08.03.25GlobeNewswirePress Release: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD

05.03.25GlobeNewswirePress release: Sanofi successfully prices EUR 1.5 billion of bond issue

25.02.25GlobeNewswirePress Release: Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma

24.02.25ZacksThe Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis

22.02.25GlobeNewswirePress Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease

19.02.25GlobeNewswirePress Release: Sanofi and CD&R sign Opella share purchase agreement

18.02.25GlobeNewswirePress Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid

13.02.25GlobeNewswirePress Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

13.02.25GlobeNewswirePress Release: Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

07.02.25GlobeNewswirePress Release: Execution of a share buyback agreement for up to €2 billion

03.02.25BenzingaSanofi Buys Back ~$3 Billion In Shares From L'Oréal: Details

03.02.25GlobeNewswirePress Release: Sanofi announces buy back of shares from L’Oréal

31.01.25GlobeNewswirePress Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

30.01.25MotleyFoolSanofi (SNY) Q4 2024 Earnings Call Transcript

30.01.25ZacksSanofi Misses on Q4 Earnings & Sales, Expects Higher Profits in 2025

30.01.25Business TimesSanofi plans 5 billion-euro buyback, sees higher profit growth

30.01.25GlobeNewswirePress Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

29.01.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - December 2024

22.01.25BenzingaSanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses

22.01.25GlobeNewswirePress Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

21.01.25GlobeNewswirePress Release: Opella reaches study milestone for Cialis

15.01.25GlobeNewswireSanofi: Information concerning the total number of voting rights and shares – November 2024

13.01.25GlobeNewswirePress Release: Sarclisa obtains first approval in China for the treatment of adult patients with relapsed or refractory multiple myeloma

10.01.25BenzingaPrice Over Earnings Overview: Sanofi

09.01.25GlobeNewswirePress Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

07.01.25ZacksSanofi Down 10% in 3 Months: How Should You Play the Stock?

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.